Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally effective ...

Please provide your email address to receive an email when new articles are posted on . Patients with a family history of diabetes had a threefold higher risk for diabetes-related comorbidities. These ...

In recent years, evidence has continued to mount showing a strong relationship between diabetes, cardiovascular disease, and chronic kidney disease. This, in turn, has driven a shift to a more ...

Smart grab-and-go snack choices include dry-roasted legumes, popcorn, hummus and veggies, nuts and cheese, yogurt, and protein bars. Aim for snacks with under 10 g of added sugar, at least 3 grams of ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

The scenario of chronic kidney disease (CKD) management has been transformed by the advent of sodium glucose co-transporter-2 (SGLT2) inhibitors, a class of drugs with benefits extending well beyond ...

Most cases of chronic kidney disease relate to underlying conditions, so the best treatment for you depends on your health ...

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious ...

Patients with chronic hepatitis B have an increased prevalence of chronic kidney disease, according to a recent study.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Finerenone was associated with lower risks for primary ...

Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic kidney disease (CKD), according to a study ...